✦ LIBER ✦

Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies

✍ Scribed by Lee, Si-Huei; Chan, Rai-Chi; Chang, Shy-Shin; Tan, Yin-Ling; Chang, Kai-Hsiang; Lee, Matthew C.; Chang, Huai-En; Lee, Chien-Chang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN1 Bisphosphonates and Risk of Osteone

✍ Leung, H.W.; Chan, A.L.; Ko, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Systemic sclerosis (scleroderma) and can

✍ Bonifazi, M.; Tramacere, I.; Pomponio, G.; Gabrielli, B.; Avvedimento, E. V.; La 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 625 KB

Su1021 Use of Oral Bisphosphonates and R

✍ Thosani, Nirav; Thosani, Sonali; Kumar, Sheetanshu; Nugent, Zoann; Jimenez, Cami 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Bisphosphonate treatment and risk of eso

✍ K. Sun, J. M. Liu, H. X. Sun, N. Lu, G. Ning 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

Bisphosphonates-Associated Osteonecrosis

✍ Lin, H.C.; Lin, S.J.; Chan, A.L 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Risk of osteonecrosis in patients taking

✍ Lee, S.-H.; Chang, S.-S.; Lee, M.; Chan, R.-C.; Lee, C.-C. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 304 KB